BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 28916201)

  • 21. Effect of conditional knockout of the type II TGF-beta receptor gene in mammary epithelia on mammary gland development and polyomavirus middle T antigen induced tumor formation and metastasis.
    Forrester E; Chytil A; Bierie B; Aakre M; Gorska AE; Sharif-Afshar AR; Muller WJ; Moses HL
    Cancer Res; 2005 Mar; 65(6):2296-302. PubMed ID: 15781643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis.
    Edovitsky E; Elkin M; Zcharia E; Peretz T; Vlodavsky I
    J Natl Cancer Inst; 2004 Aug; 96(16):1219-30. PubMed ID: 15316057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MMTV-PyMT and Derived Met-1 Mouse Mammary Tumor Cells as Models for Studying the Role of the Androgen Receptor in Triple-Negative Breast Cancer Progression.
    Christenson JL; Butterfield KT; Spoelstra NS; Norris JD; Josan JS; Pollock JA; McDonnell DP; Katzenellenbogen BS; Katzenellenbogen JA; Richer JK
    Horm Cancer; 2017 Apr; 8(2):69-77. PubMed ID: 28194662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heparanase induces vascular endothelial growth factor expression: correlation with p38 phosphorylation levels and Src activation.
    Zetser A; Bashenko Y; Edovitsky E; Levy-Adam F; Vlodavsky I; Ilan N
    Cancer Res; 2006 Feb; 66(3):1455-63. PubMed ID: 16452201
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heparanase promotes growth, angiogenesis and survival of primary breast tumors.
    Cohen I; Pappo O; Elkin M; San T; Bar-Shavit R; Hazan R; Peretz T; Vlodavsky I; Abramovitch R
    Int J Cancer; 2006 Apr; 118(7):1609-17. PubMed ID: 16217746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular mechanisms of melatonin anticancer effects.
    Hill SM; Frasch T; Xiang S; Yuan L; Duplessis T; Mao L
    Integr Cancer Ther; 2009 Dec; 8(4):337-46. PubMed ID: 20050373
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heparanase: Historical Aspects and Future Perspectives.
    Khanna M; Parish CR
    Adv Exp Med Biol; 2020; 1221():71-96. PubMed ID: 32274707
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heparanase Accelerates Obesity-Associated Breast Cancer Progression.
    Hermano E; Goldberg R; Rubinstein AM; Sonnenblick A; Maly B; Nahmias D; Li JP; Bakker MAH; van der Vlag J; Vlodavsky I; Peretz T; Elkin M
    Cancer Res; 2019 Oct; 79(20):5342-5354. PubMed ID: 31481501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transgenic mice with mammary gland targeted expression of human cortactin do not develop (pre-malignant) breast tumors: studies in MMTV-cortactin and MMTV-cortactin/-cyclin D1 bitransgenic mice.
    van Rossum AG; van Bragt MP; Schuuring-Scholtes E; van der Ploeg JC; van Krieken JH; Kluin PM; Schuuring E
    BMC Cancer; 2006 Mar; 6():58. PubMed ID: 16536875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epithelial mesenchymal transition is a characteristic of hyperplasias and tumors in mammary gland from MMTV-Cripto-1 transgenic mice.
    Strizzi L; Bianco C; Normanno N; Seno M; Wechselberger C; Wallace-Jones B; Khan NI; Hirota M; Sun Y; Sanicola M; Salomon DS
    J Cell Physiol; 2004 Nov; 201(2):266-76. PubMed ID: 15334661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A functional heparan sulfate mimetic implicates both heparanase and heparan sulfate in tumor angiogenesis and invasion in a mouse model of multistage cancer.
    Joyce JA; Freeman C; Meyer-Morse N; Parish CR; Hanahan D
    Oncogene; 2005 Jun; 24(25):4037-51. PubMed ID: 15806157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of LMO4 induces mammary hyperplasia, promotes cell invasion, and is a predictor of poor outcome in breast cancer.
    Sum EY; Segara D; Duscio B; Bath ML; Field AS; Sutherland RL; Lindeman GJ; Visvader JE
    Proc Natl Acad Sci U S A; 2005 May; 102(21):7659-64. PubMed ID: 15897450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Newly generated heparanase knock-out mice unravel co-regulation of heparanase and matrix metalloproteinases.
    Zcharia E; Jia J; Zhang X; Baraz L; Lindahl U; Peretz T; Vlodavsky I; Li JP
    PLoS One; 2009; 4(4):e5181. PubMed ID: 19360105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced genetic instability and dasatinib sensitivity in mammary tumor cells lacking NEDD9.
    Singh MK; Izumchenko E; Klein-Szanto AJ; Egleston BL; Wolfson M; Golemis EA
    Cancer Res; 2010 Nov; 70(21):8907-16. PubMed ID: 20940402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heparanase enhances syndecan-1 shedding: a novel mechanism for stimulation of tumor growth and metastasis.
    Yang Y; Macleod V; Miao HQ; Theus A; Zhan F; Shaughnessy JD; Sawyer J; Li JP; Zcharia E; Vlodavsky I; Sanderson RD
    J Biol Chem; 2007 May; 282(18):13326-33. PubMed ID: 17347152
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estrogen receptor-alpha expression in the mammary epithelium is required for ductal and alveolar morphogenesis in mice.
    Feng Y; Manka D; Wagner KU; Khan SA
    Proc Natl Acad Sci U S A; 2007 Sep; 104(37):14718-23. PubMed ID: 17785410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Constitutive overexpression of Id-1 in mammary glands of transgenic mice results in precocious and increased formation of terminal end buds, enhanced alveologenesis, delayed involution.
    Shin DH; Jang SH; Kang BC; Kim HJ; Oh SH; Kong G
    J Cell Physiol; 2011 May; 226(5):1340-52. PubMed ID: 20945346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heparanase induces signal transducer and activator of transcription (STAT) protein phosphorylation: preclinical and clinical significance in head and neck cancer.
    Cohen-Kaplan V; Jrbashyan J; Yanir Y; Naroditsky I; Ben-Izhak O; Ilan N; Doweck I; Vlodavsky I
    J Biol Chem; 2012 Feb; 287(9):6668-78. PubMed ID: 22194600
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The matrix metalloproteinase matrilysin influences early-stage mammary tumorigenesis.
    Rudolph-Owen LA; Chan R; Muller WJ; Matrisian LM
    Cancer Res; 1998 Dec; 58(23):5500-6. PubMed ID: 9850086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dominant negative retinoic acid receptor initiates tumor formation in mice.
    Kupumbati TS; Cattoretti G; Marzan C; Farias EF; Taneja R; Mira-y-Lopez R
    Mol Cancer; 2006 Mar; 5():12. PubMed ID: 16563162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.